Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Feb;15(2):155-62.
doi: 10.3201/eid1502.081031.

Oseltamivir-resistant influenza viruses A (H1N1), Norway, 2007-08

Affiliations

Oseltamivir-resistant influenza viruses A (H1N1), Norway, 2007-08

Siri H Hauge et al. Emerg Infect Dis. 2009 Feb.

Abstract

In Norway in January 2008, unprecedented levels of oseltamivir resistance were found in 12 of 16 influenza viruses A (H1N1) tested. To investigate the epidemiologic and clinical characteristics of these viruses, we used sequence analysis to test all available subtype H1N1 viruses from the 2007-08 season for resistance. Questionnaires from physicians provided information on predisposing diseases, oseltamivir use, symptoms, and complications. Clinical data were obtained for 265 patients. In total, 183 (67.3%) of 272 viruses were oseltamivir resistant. Resistance was not associated with prior use of antiviral drugs. Symptoms and hospitalization rates did not differ for patients infected with a resistant or a susceptible virus. Oseltamivir-resistant influenza viruses A (H1N1) did not show diminished capability to spread in the absence of selective pressure. The ability of these viruses to sustain their fitness and spread among persons should be considered when shaping future strategies for treating and preventing seasonal and pandemic influenza.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Phylogenetic reconstruction of the H1 genes of influenza viruses A (H1N1) in Norway, 2007–08 season. The analysis was performed on an alignment spanning positions 84–1054 of viral RNA segment 4. Pairwise distances were calculated by using the Kimura 2-parameter model with a transition:transversion ratio of 2.0; the phylogenetic tree was constructed by the neighbor-joining method, as implemented in the programs DNADIST and NEIGHBOR in the PHYLIP package (14 15,). Published sequences were obtained from the Influenza Sequence Database, Los Alamos National Laboratory (16). Boldface indicates viruses from the 2007–08 influenza season in Norway; red indicates oseltamivir-resistant viruses; blue, susceptible viruses. New sequences presented in this analysis have been deposited in GenBank (accession nos. CY036664–CY036694).
Figure 2
Figure 2
Oseltamivir-resistant (n = 183) and oseltamivir-susceptible (n = 89) influenza viruses A (H1N1) in the 2007–08 influenza season in Norway, by week of sampling.
Figure 3
Figure 3
Comparison of virus shedding, measured as relative viral RNA content, in respiratory specimens taken from patients infected with oseltamivir-susceptible and oseltamivir-resistant influenza viruses A (H1N1), respectively, during the 2007–08 influenza season in Norway. Viral RNA content is expressed as the reverse-transcription–PCR cycle number (Ct) during which the fluorescence threshold was exceeded.
Figure 4
Figure 4
Proportion of oseltamivir-resistant influenza viruses A (H1N1) in the 2007–08 influenza season in Norway, by county of sampling. The total number of samples analyzed for each county is given inside each county.

Similar articles

Cited by

References

    1. McKimm-Breschkin J, Trivedi T, Hampson A, Hay A, Klimov A, Tashiro M, et al. Neuraminidase sequence analysis and susceptibilities of influenza virus clinical isolates to zanamivir and oseltamivir. Antimicrob Agents Chemother. 2003;47:2264–72. 10.1128/AAC.47.7.2264-2272.2003 - DOI - PMC - PubMed
    1. Aavitsland P, Hauge S, Borgen K. Rare usage of oseltamivir in Norway prior to emergence of oseltamivir resistant influenza A(H1N1) virus in the 2007–2008 season. 2008. International Conference on Emerging Infectious Disases; 2008 Mar 16–19; Atlanta. Addendum 11.
    1. Escuret V, Frobert E, Bouscambert-Duchamp M, Sabatier M, Grog I, Valette M, et al. Detection of human influenza A (H1N1) and B strains with reduced sensitivity to neuraminidase inhibitors. J Clin Virol. 2008;41:25–8. 10.1016/j.jcv.2007.10.019 - DOI - PubMed
    1. Monto AS, McKimm-Breschkin JL, Macken C, Hampson AW, Hay A, Klimov A, et al. Detection of influenza viruses resistant to neuraminidase inhibitors in global surveillance during the first 3 years of their use. Antimicrob Agents Chemother. 2006;50:2395–402. 10.1128/AAC.01339-05 - DOI - PMC - PubMed
    1. Zambon M, Hayden FG. Position statement: global neuraminidase inhibitor susceptibility network. Antiviral Res. 2001;49:147–56. 10.1016/S0166-3542(01)00124-3 - DOI - PubMed

LinkOut - more resources